MFM Flashcards

1
Q

CF

A

Carrier 1:35
Affected 1:5000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Spinal muscular atrophy

A

1:50 carrier
1:10,000 affected
Severe muscular weakness, death, usually in childhood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fragile X

A

1:300 carrier
1:7000 males affected
Severe intellectual disability and autism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Trisomy 21

A

1:660 births

Features vary secondary to mosaicism

Features in neonates
- Hypotonia
Facial characteristics - short, webbed neck, low nasal bridge, epicanthal folds, upward slanting of eyes
- Cardiac or GI manifestations
- Brachycephaly

infancy: developmental delay

Intellectual disability, GI malformations, Auditory and / or visual defects, hypothyroidism, epilepsy,

55 is average age

Recurrence - maternal age <35 = 1/100
>35 = twice population risk

If familial Robertsonian translocations: recurrence 1% for male, and 12% for female

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Trisomy 13 - Patau syndrome

A

1:5000 births

4/7 of life average length - cardiac defects, poor brain stem control.

Sometimes can get partial or mosaic trisomy 13 which means less severe

Craniofacial malformations, ocular malformations, neurological malformations, limb abnormalities, cardiovascular abnormalities, omphalacele, diaphragm abnormalities, etc…..
severe intellectual disability

Recurrence low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Trisomy 18 - Edwards syndrome

A

1:3000 births

Not usually compatible with prolonged survival

Features can be less severe in case of mosacism

Severe developmental delay
Multiple malformations including cardiac, urinary tract, renal, joint contractures, low birth weight, hearing loss, rocker bottom feet,

Severe developmental delay and disability

Of those babies that are liveborn, 30% die in the first month of life and 90% die by 12 months

Recurrence low!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Klinefelter syndrome 47XXY

A

1:500 - 1000 births

Primary hypogonadism
Pubertal gynaecomastia and small testes
Tall stature
Infertile
Delayed language

Refer to paeds endocrinologist for treatment with testosterone (function of testes not restored) Occ men can be fertile by ICSI

Recurrence risk low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Turner syndrome XO

A

1:2000 births
Poor growth, pubertal delay
short stature
lack of sexual development at puberty and streak ovaries, primary amenorrhoea, infertility, normal intelligence

Webbed neck, heart defects, renal abnormlaities,

Majority will be mosaic in some tissues

FSH raised
Refer paeds endocrinologist
Give E and GH
HTN - treat
Frequent otitis media
Refer for IVF
Increased risk IBD, hypothyroid, diabetes

Sleeping issues
Deefing difficulties (high arched palate or cleft)

Recurrence risk low!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Toxoplasmosis main points

A

Acute infection in mother usually asymptomatic
If immunocompetent don’t transmit to fetus
Risks:
1st trimester 10% transmission, 90% fetal damage
2nd trimester: 40% transmission, 20% fetal damage
3rd trimester 90% transmission, 10% damage

Risk to fetus: fetal liver and brain calcifications, ventriculomegaly, non immune hydrops, death, IUGR
Triad: chorioretinitis, hydrocephalus, intracranial calcifications - if no treatment high risk of abnormality CNS and vision impairment

Do IgM and IgG serology with IgG avidity, and repeat 2/52

M -MFM referral
U - tertiary USS
T - already done TORCH
A - amniocentesis PCR >4/52 from infection (do not do <18/40), can have false negatives
N - NICU consult
T - TOP consider
I - Written INFO
S - Social work
M - management particular to condition
- Spiramycin 1g TDS until delivery (significantly reduces the proportion of infected fetuses that develop severe neurological sequelae)
If fetal infection confirmed or even if fetal infection not confirmed on PCR: add pyrimethamine and sulfadiazine and folinic acid
If fetal infection confirmed consider TOP

If fetal infection not confirmed still do monthly USS to assess for brain changes

Management of infant: ophathlmologist, auditory, neurology review, head USS / MRI, lab serology - IgM and IgG, PCR bloods / CSF / placenta. Treatment for one year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Listeria main points

A

40-50% risk IUFD in second / third trimester
Amoxicillin IV ≥2g q4-6h for 2/52
Urgent delivery depending on severity of maternal illness / gestation

Full septic screen on neonate - can die, granulomas, meconium, pneumoniits, conjunctivitis –> given amoxicllin regardless and if CSF positive - longer term.

Can be early or late onset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hydrops mnemonic

A

CAUSTIC

C - chromosomal (turners, trisomy 13, 18, 21, noonans)
A - anaemia - parvo, rhesus disease, FMH, alpha thalassaemia, G6PD, TAPS
U - unexplained e.g. metabolic?
S - Structural - Chest: CCAM, CDH, chylothorax, skeletal dysplaisa, GI and GU abnormalities, placental / fetal tumours
T - Twins - TTTS / TAPS, TRAP
I - Infection - parvovirus, coxasackie, STORCH, Varicella
C - Cardiac - tachyarrhytmia, bradyarrhythmia, high output state, cardiac structural anomaly

  • Pertinent questions
    o Any recent viral infections? (fever, rash, lymphadenopathy)
    o Recent trauma / fall – large FMH
    o Ethnicity, consanguinity, and family history (alpha thalassaemia, G6PD)
    o Any suggestion of SLE or Sjogrens (anti Ro/La and heart block)
    o Profession – childcare worker, teacher, risk of infections

Examination – Key points
- General inspection
- Vitals: temperature, BP, oxygen saturations (mirror syndrome)
- Cardiorespiratory: pulmonary and peripheral oedema, hyperreflexia, clonus (mirror syndrome)
- Obstetric exam
o Fundal height
o Subjective assessment of amniotic fluid
o Presentation and lie
o Any fetal movements felt
o Fetal heart / CTG if suitable gestation

Ix
- G+H and titre if Ab positive
- Kleihauer
- PET screen (mirror)
- FBC / DNA studies / partner testing
- G6PD screen if ethnicity suggestive (jews, nigerians, thai etc)
- TORCH screen (toxo, syphilis, varicella, zika, rubella, CMV, HSV)
- Anti Ro / La if bradyarrhythmia
- TFTs and TSHRAb if tachycarrhtymia
- CTG if suitable

Ultrasound
- Tertiary view for structural anomalies
- Fetal ECHO
- MCA PSV for fetal anaemia and sometimes fetal blood sample
- Growth and wellbeing (UAPI, MCA, CPR, DV)
- Compartments affected

Amniocentesis
- PCR for infections
- Chromosomal microarray

Prognosis
- If born with hydrops 50% risk mortality - dependent on cause
Chromosomal abnormality poor prognosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fetal echogenic bowel

A

If isolated = good prognosis, 1% in second trimester

Fetal aneuploidy (T21&raquo_space; T13, T18)
meconium
Intra-amniotic bleeding - swallowing of blood
Congenital malofromations of bowel
IUGR
Congenital infection
FAS, alpha thalassaemia homozygous
CF

Offer
NIPT
TORCH screen
Genetic carrier screening
Tertiary anatomy scan
Amnio
MFM
Monthly growth scans

(MUTANTISM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Choroid plexus cyst

A

in Isolation not a big deal
Offer NIPT
Not for invasive testing if no other abnormalities
Can be ass with T21 and T18 (1%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neural tube defect

A

Neural tube closes day 21 - 28

Open defects - myelomeingocele (open spinal cord, no skin), meningocele (protrusion of membranes), encephalocele (protrusion brain from part of skull) , anencephaly (missing part of skull)
Closed NTDs: spina bifida

Prevalence
5-20 / 10,000 births

5mg folic acid if
- Prev child with NTD, mother with NTD, close family member with NTD.
- Insulin treatment for diabetes
- Antiepileptic treatment - carbamazepine, sodium valproate

Screen everyone, majority found in first trimester

Prolonged exposure of neural tissue to amniotic fluid can cause injury to the cord - MSK weakness, bowel and genitourinary dysfunction

M - MFM referral
U - USS: Screen for other abnormalities - oral clefts, malformations in MSK, renal, cardiovascular systems
T - not needed
A - offer microarray 6% risk chromosomal abnormality
N - NICU
T - TOP if severe
I - written info
S - SW
M - management as per condition - can sometimes consider fetal surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Myelomeningocele signs / important facts

A

Lemon sign - frontal bone scalloping
Banana sign: abnormal cerebellum

Ass with Arnold Chiari II malformation with caudal displacement of brain

Ass with T 18, maternal diabetes, AEDs
Risk of non chromosomal abnormalities low

MUTANISM

4 weekly growth
Aim NVB
Prognosis: 35% 5 year mortality rate, 20% die in first 12/12, 25% stillborn
Surviving infants usually have paralysis in the lwoer limbs, double incontinence, hydrocephalus. Normal intelligence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Recurrence rate NTD

A

One sibling or parent = 5%
Two affected siblings 10%

75% reduction if high dose folate

17
Q

Anencephaly

A

Failure of rostral neuropore to close
Most are stillborn or die shortly after birth
Chromosomal defects are rare

Recurrence
1 affected sibling 5%
2 affected siblings 10%

18
Q

Encephalocele

A

Cranial bone defect with herniated fluid filled or brain filled cyst
Chromosomal defects T13, T18 10%
Other syndromes also ass incl amniotic band syndrome

MUTANISM
Paeds surg
38/40 IOL
CS to avoid trauma to brain

Mortality is high if posterior encephaocele 50%
20% anterior
Neurological handicap in >50% of survivors

Recurrence
- Isolated 5%
Part of trisomies 1%
Part of autosomal recessive conditions 25%

19
Q

Management of DCDA twin pregnancy
AN
Delivery
PN

A

Risks: PTB, FGR, growth discordance (>20% discordance = needs increased monitoring), HTN, PET

11-14/40 appt with ANC
20,24,28,32,36 /40 appt with USS
Also 16 and 34 weeks without USS

Delivery by end of 37th week otherwise increased risk stillbirth
Birth in hospital, epidural, CEFM, IVL, NVB if cephalic twin 1
CS if not

20
Q

MCDA twins
Risks
AN
Delivery
PN

A

Risks
Higher rates of structural abnormalities
TTTS (15% of MCDA twins - see separate flash card)
PTB, FGR, growth discordance (>20% discordance = needs increased monitoring), HTN, PET

11-14/40 appt AND every 2/52 from 16/40 with MCA

Deliver by end of 36th week
OK for NVB if
- pregnancy uncomplicated and has progressed past 32/40
- No obstetric contraindications
- First baby cephalic
- No significant size discordance
>1/3 will have a CS if planned vaginal birth, incl 2nd twin
Risk actue twin to twin transfusion

MCMA: 32-33+6 - CS. High risk cord entanglement

21
Q

Triplet pregnancies ANC reviews

A

Consider selective reduction

TCTA: 11-14/40 and then 16 and 20/40, then 2 weekly from 24/40

DCTA or MCTA - 11-14/40 then 2 weekly from 16 weeks

Monoamniotic anything - individualised care in FM

Greater risk of Down’s syndrome, Edward’s syndrome, Patau’s syndrome and increased risk of false positives
Only MSS1 or NIPT can be used

Deliver by 35/40 TCTA or DCTA
CS

22
Q

TTTS

A

Vascular anastamoses running between two fetal umbilical cords within and on the surface of the placenta - bidirectional.

Monitor for rapidly increase girth and SOB
Scan from 16 weeks, every 2 weeks (to prevent late stge disease intervention, rare after 26/40)
- DVP (>4cm difference - abnormal - so increase frequency of scanning / doppler assessments)
- Urgent FM review if DVP <2cm and other baby >8cm (<20/40), or >10cm (from 20/40)
Less urgent referral if one is in normal range and one is <2cm or >8cm
Discordant bladder appearances

Donor: hypovolaemia, oliguria, oligohydramnios, empty bladder, poor growth, abnormal UAPI, cardiac dysfunction

Recipient: hypervolaemia, hypertension, polyuria, polyhydramnios, cardiomyopathy

Classical TTTS: TOPS 10% of Monochorionic twins.
- Type 1: Significant difference in DVP (<2cm, >8-10cm)
- Type 2: Bladder of donor twin not visible and severe oligohydramnios. Dopplers are not critically abnormal
- Type 3: Dopplers critically abnormal in either. (donor gets abnormal UAPI, recipient gets abnormal DV)
- Type 4: Ascites, pericardial or pleural effusion, scalp oedema or overt hydrops in recipient
- Type 5: One or both babies have died

Survival rates
Type 1: 90%
Type II and III 83%
Type 4 70%

Management
- Fetoscopic laser ablation recommended from stage 2 - 4
- Aim is to interrupt placental anastomoses causing TTTS
- Sometimes severe cases can be managed with selective reduction especially if abnormality of one twin, 20% risk of loss of cotwin.
- Consider TOP if TTTS remote from viability
- TAPS can occur (anaemia, polycythaemia sequence)
- 10-30% risk procedure related loss, PPROM 35%
- Risk cerebral palsy, IVH
- Consider MRI for all twins post laser
Delivery 34 - 36+6/40
Consider steroids at time of laser

TAPS
- 5% of MC twins, 10% after laser
Slow transfusion from one twin to another
Characterised by significantly discordant MCA PSV
This is why after 20/40 UAPI and MCA dopplers should be reviewed
Cardiomegaly in donor
Postnatal diagnosis Hb difference of 80
Mortality 9% overall (donors more than recipients)
Haemotological complications, renal impairments, severe cerbral injury, necrosis of skin, limb ischaemia, severe neurodevelopmental injury, mild cognitive impairment, deafness

Mx TAPS
- Expectant - 16% spontaneous resolution
>32/40 - Delivery
Selective reduction sometimes required
28-32/40: IUT to buy time
<28/40 - consider fetoscopic laser, more challenging than for TTTS

Staging
1 - Donor MCA PSV >1.5MoM and recipient <1
2 - Donor >1.7MoM, and recipient <0.8
3 - Stage 1 or 2 with cardiac compromise in donor/ abnormal dopplers
4 - hydrops of donor twin
5 - Death

23
Q

Selective growth discordance

A

Type 1: growth discordance but +ve diastolic velocities in umbilical arteries - good prognosis, delivery 34-36/40

Type 2: Growth discordance with AREDV, 30% risk IUFD. INPATIENT CARE

Type 3: cyclical umbilical artery diastolic waveforms (+ve, absent and reversed in cyclical pattern). Low risk for hypoxia. Can prolong pregnancy >32/40 but 10-15% of unexpected IUFD . INPATIENT CARE

Mx
- MFM
Selective reduction an option
Twice weekly scans - UAPI, MCAPI, MCA VMax, DV
Delivery when reversed DV flow
Type 2 and 3 manage as inpatient with twice weekly USS, BD CTG, steroids, deliver by 32/40 unless required earlier
May still be adverse outcomes despite close monitoring

Cerebral palsy rate increased regardless of birth weight and GA at birth

Could consider just sacrificing one twin and going closer to term for the other twin

24
Q

Death of one twin

A

Risk of death in other twin 15%
Risk of neurological disability in other twin - 26%
Acute transfusion to dead twin
Thromboplastins released from dead twin

MRI 4/52 down the line
MCA surveillance for surviving twin

Potential for TRAP - twin reversed arterial perfusion sequence, surviving twin continues to perfuse the deceased twin’s body (only first trimester really). Some managed with conservatively, some with operation. Can cause transient hypotension and low perfusion